Earnings Per Share, Basic in USD/shares of Context Therapeutics Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Context Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q3 2020 to Q3 2025.
  • Context Therapeutics Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.1 USD/shares, a 54.5% increase year-over-year.
  • Context Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0 USD/shares, a 76.9% increase year-over-year.
  • Context Therapeutics Inc. annual Earnings Per Share, Basic for 2024 was -0.46 USD/shares, a 69.3% increase from 2023.
  • Context Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -1.5 USD/shares, a 61.3% decline from 2022.
  • Context Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -0.93 USD/shares, a 74.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Context Therapeutics Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 +$0.12 +54.5% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $0 $0 $0 -125% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $0 $0 +$0.18 +78.3% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $0 $0.03 +$0.45 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 $0 $0 +$0.15 +40.5% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$1 $0 +$0.27 +87.1% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 -$1 $0 +$0.17 +42.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 -$1 $0 $0 -90.9% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$1 $0 $0 -54.2% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$1 $0 $0 -24% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 -$1 $0 $0 -81.8% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $0 $0 -$17 -101% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 $16.00 $0 +$3.76 +94% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $12.00 $0 +$13.90 +98.2% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 -$1 $0 +$2.33 +91.4% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 -$3 $17.00 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 -$4 -$1 -58.7% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$14 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$3 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 -$3 01 Jul 2020 30 Sep 2020 10-Q 02 Dec 2021

Context Therapeutics Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 +$1.04 +69.3% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$2 -$1 -61.3% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$1 +$2.76 +74.8% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$4 -$7 -220% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 $3.07 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.